Table 4 Comparison of prognosis of elderly and non-elderly patients
Adverse event (High Level Group Term) | RR (95%CI) | χ2 |
|---|---|---|
Especially the prognostic comparison of AEs characterized by the elderly | ||
Glaucoma and ocular hypertension | 0.33 (0.12–0.92) | 0.32 |
Impulse control disorders NEC | 0.08 (0.01–1.10) | 0.09 |
Neurological special senses and psychiatric investigations | 1.00 (1.00–1.00) | NA |
Injuries by physical agents | 0.33 (0.01–12.81) | 0.37 |
Personality disorders and disturbances in behaviour | 1.91 (0.10–34.92) | 0.13 |
Neurological disorders of the eye | 0.67 (0.27–1.63) | 0.04 |
Manic and bipolar mood disorders and disturbances | 0.71 (0.02–25.32) | 0.86 |
Movement disorders (include parkinsonism) | 0.35 (0.04–3.46) | 0.10 |
Enzyme investigations NEC | 0.23 (0.02–2.73) | 0.06 |
Disturbances in thinking and perception | 0.39 (0.01–16.90) | 0.42 |
Vision disorders | 4.85 (0.35–66.36) | 0.99 |
Ocular infections irritations and inflammations | 0.47 (0.21–1.00) | 0.53 |
Prognostic comparison of other AEs | ||
Deliria (include confusion) | 3.91 (0.22–68.39) | 0.30 |
Product use issues | 0.67 (0.09–4.83) | 0.02 |
Sleep disturbances (include subtypes) | 1.82 (0.23–14.26) | 0.004 |
Sleep disturbances | 1.53 (0.33–7.13) | 0.02 |
Psychiatric and behavioural symptoms NEC | 2.88 (0.71–11.73) | 1.55 |
Dementia and amnestic conditions | 0.80 (0.06–11.50) | 0.33 |
Suicidal and self-injurious behaviours NEC | 0.95 (0.48–1.89) | 0.02 |
Mental impairment disorders | 0.87 (0.06–12.52) | 0.40 |
Neurological disorders NEC | 1.18 (0.47–2.91) | 0.01 |
Psychiatric disorders NEC | 0.31 (0.04–2.65) | 0.46 |
Respiratory disorders NEC | 0.48 (0.27–0.87) | 5.54 |
Injuries NEC | 1.20 (0.37–3.93) | 0.01 |
Changes in physical activity | 0.80 (0.07–9.18) | 0.39 |
Changes in physical activity | 0.80 (0.07–9.18) | 0.39 |
Therapeutic and nontherapeutic effects (exclude toxicity) | 0.44 (0.02–9.61) | 0.04 |
Depressed mood disorders and disturbances | 1.5 (0.13–17.67) | 0.23 |